Abeona Therapeutics Inc.
ABEO
$4.84
$0.245.22%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -16.59M | -11.84M | -16.65M | -9.11M | -7.12M |
| Total Depreciation and Amortization | 721.00K | 751.00K | 838.00K | 888.00K | 1.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.62M | 2.98M | 8.69M | -1.51M | -3.88M |
| Change in Net Operating Assets | 1.02M | 2.36M | -3.15M | -2.01M | -4.00M |
| Cash from Operations | -9.24M | -5.75M | -10.28M | -11.74M | -13.99M |
| Capital Expenditure | -37.00K | -44.00K | -32.00K | -218.00K | -25.00K |
| Sale of Property, Plant, and Equipment | 17.00K | 8.00K | 179.00K | -- | 144.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.55M | -18.71M | 5.06M | 2.43M | -25.41M |
| Cash from Investing | 11.53M | -18.74M | 5.21M | 2.21M | -25.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.79M | 22.98M | 6.62M | -- | 42.77M |
| Repurchase of Common Stock | -182.00K | -- | -- | -- | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.00K | -4.00K | -5.00K | -4.00K | -- |
| Cash from Financing | 7.47M | 22.98M | 6.62M | -4.00K | 42.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.76M | -1.51M | 1.55M | -9.54M | 3.48M |
